JN.1 Makes Up 62% of Circulating COVID-19 Variants

Illness caused by respiratory viruses continues to increase across the US. As of January 6, the COVID-19 variant JN.1 accounted for 62% of circulating variants in the U.S.

Seasonal influenza activity is elevated and continues to increase. The CDC estimates there have been at least 10 million illnesses, 110,000 hospitalizations, and 6,500 deaths from flu so far this season.

RSV activity remains elevated in many areas of the country causing increased hospitalization rates, especially among young children and older adults. CDC provides a weekly snapshot of respiratory virus data. For healthcare providers, the 2024 Immunization Schedules are now available and effective immediately.

COVID-19 Hospitalizations, ED Visits and Deaths Increase

The greatest number of COVID-19 cases continue to be seen in adults 75 years and older.

Long-term care facilities are seeing an increase in confirmed COVID-19 cases, reporting 13.3/1000 cases for the week ending December 31.

Vaccination remains a vital tool to protect public health. One dose of the updated 2023-2024 Moderna, Pfizer, or Novavax vaccine is required for individuals to be considered up to date.

You can make a difference. Help keep your community safe and healthy. Remember to WAVE - ask "What About Vaccines?" at Every Encounter.

CDC Hosts Webinar on NHSN Weekly COVID-19 Vaccination Healthcare Personnel Summary Reporting